HK1038019A1 - Process for preparing substituted pyridines. - Google Patents

Process for preparing substituted pyridines.

Info

Publication number
HK1038019A1
HK1038019A1 HK01108923A HK01108923A HK1038019A1 HK 1038019 A1 HK1038019 A1 HK 1038019A1 HK 01108923 A HK01108923 A HK 01108923A HK 01108923 A HK01108923 A HK 01108923A HK 1038019 A1 HK1038019 A1 HK 1038019A1
Authority
HK
Hong Kong
Prior art keywords
substituted pyridines
preparing substituted
preparing
pyridines
substituted
Prior art date
Application number
HK01108923A
Other languages
English (en)
Inventor
Robert Lee Dow
Steven Roy Schneider
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HK1038019A1 publication Critical patent/HK1038019A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • C07F7/1872Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • C07F7/1872Preparation; Treatments not provided for in C07F7/20
    • C07F7/188Preparation; Treatments not provided for in C07F7/20 by reactions involving the formation of Si-O linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HK01108923A 2000-03-31 2001-12-20 Process for preparing substituted pyridines. HK1038019A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19377200P 2000-03-31 2000-03-31

Publications (1)

Publication Number Publication Date
HK1038019A1 true HK1038019A1 (en) 2002-03-01

Family

ID=22714938

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01108923A HK1038019A1 (en) 2000-03-31 2001-12-20 Process for preparing substituted pyridines.

Country Status (26)

Country Link
US (4) US6518431B2 (id)
EP (1) EP1138685B1 (id)
JP (1) JP2001316393A (id)
KR (2) KR100435128B1 (id)
CN (1) CN1191235C (id)
AR (1) AR033812A1 (id)
AT (1) ATE267204T1 (id)
AU (1) AU782272B2 (id)
BR (1) BR0101280A (id)
CA (1) CA2342571A1 (id)
CZ (1) CZ20011194A3 (id)
DE (1) DE60103317T2 (id)
DK (1) DK1138685T3 (id)
ES (1) ES2217090T3 (id)
HK (1) HK1038019A1 (id)
HU (1) HUP0101332A3 (id)
ID (1) ID29728A (id)
MX (1) MXPA01003383A (id)
PL (1) PL346805A1 (id)
PT (1) PT1138685E (id)
RU (1) RU2223956C2 (id)
SI (1) SI1138685T1 (id)
TR (1) TR200401359T4 (id)
TW (1) TW555761B (id)
YU (1) YU23301A (id)
ZA (1) ZA200102538B (id)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190122333A (ko) 2018-04-20 2019-10-30 사단법인 한국지능형교통체계협회 스터드 레일 피팅
KR102037602B1 (ko) 2018-04-20 2019-10-28 사단법인 한국지능형교통체계협회 저상 버스용 고정 바를 갖춘 휠체어 잠금장치

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559256A (en) * 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
US5705515A (en) * 1994-04-26 1998-01-06 Merck & Co., Inc. Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
AU712057B2 (en) * 1996-06-07 1999-10-28 Merck & Co., Inc. Oxadiazole benzenesulfonamides as selective beta3 agonists for the treatment of diabetes and obesity
US5792871A (en) 1996-07-22 1998-08-11 Merck & Co., Inc. Process for N-Boc-N-(R)-2(3-pyridyl)-2-hydroxy-ethyl)-N-2(4-aminophenyl)ethyl amine and 2-(4-aminophenyl)-N-2-(2(R)-hydroxy-2-phyridin-S-yl-ethyl)acetamide
EA199900692A1 (ru) * 1997-01-28 2000-02-28 Мерк Энд Ко., Инк. БЕНЗОЛСУЛЬФАМИДЫ ТИАЗОЛА КАК βАГОНИСТЫ ДЛЯ ЛЕЧЕНИЯ ДИАБЕТА И ОЖИРЕНИЯ
KR20010102198A (ko) * 1999-02-16 2001-11-15 후루타 타케시 치환 아세틸피리딘 유도체 및 그를 이용하는 광학활성 β3작용제 중간체의 제조 방법

Also Published As

Publication number Publication date
KR20010095192A (ko) 2001-11-03
KR100481603B1 (ko) 2005-04-08
US20050113578A1 (en) 2005-05-26
HUP0101332A2 (en) 2002-10-28
SI1138685T1 (en) 2004-12-31
PT1138685E (pt) 2004-08-31
RU2223956C2 (ru) 2004-02-20
HUP0101332A3 (en) 2004-07-28
EP1138685B1 (en) 2004-05-19
AU3334801A (en) 2001-12-13
ZA200102538B (en) 2002-09-30
KR100435128B1 (ko) 2004-06-09
DE60103317D1 (de) 2004-06-24
ATE267204T1 (de) 2004-06-15
ID29728A (id) 2001-10-04
DK1138685T3 (da) 2004-08-09
TW555761B (en) 2003-10-01
US20040133005A1 (en) 2004-07-08
AR033812A1 (es) 2004-01-07
US6670480B2 (en) 2003-12-30
CA2342571A1 (en) 2001-09-30
CZ20011194A3 (cs) 2002-02-13
EP1138685A3 (en) 2003-04-02
AU782272B2 (en) 2005-07-14
HU0101332D0 (en) 2001-06-28
TR200401359T4 (tr) 2004-08-23
CN1191235C (zh) 2005-03-02
PL346805A1 (en) 2001-10-08
US20030114670A1 (en) 2003-06-19
KR20030072295A (ko) 2003-09-13
DE60103317T2 (de) 2005-06-16
JP2001316393A (ja) 2001-11-13
BR0101280A (pt) 2001-11-06
ES2217090T3 (es) 2004-11-01
CN1320596A (zh) 2001-11-07
YU23301A (sh) 2003-04-30
US20020077478A1 (en) 2002-06-20
US6518431B2 (en) 2003-02-11
US6844441B2 (en) 2005-01-18
MXPA01003383A (es) 2005-08-26
EP1138685A2 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
EG23914A (en) Process for preparing an antichnolinergic
ZA200203252B (en) Process for preparing 4"-substituted-9-deoxo-9A-AZA-9A-homoerythromycina derivatives.
GB0028179D0 (en) Process for preparing pouches
ZA200102070B (en) Process for preparing resorcinol derivatives.
HUP0300160A3 (en) Process for preparing (+)-cis-sertraline
ZA200108623B (en) Process for preparing imidachloprid.
ZA200007253B (en) Process for preparing 1,4-dihydropyridine compounds.
HUP0300241A3 (en) Processes for preparing torsemide intermediate
HUP0301649A3 (en) Process for preparing azacycloalkanoylaminothiazoles
HUP0300114A3 (en) Process for preparing flavonoid-derivatives
MXPA03005569A (es) PROCEDIMIENTO MEJORADO PARA LA PREPARACION DE UN FARMACO ANTIMIGRAnOSO.
MXPA03000865A (es) Proceso para preparar 2-(4-piridil) amino-6-dialquiloxifenil-pirido (2,3-d)pirimidin-7-onas.
HK1044780A1 (en) Method for producing cyclo-)asp-dphe-nmeval-arg-gly).
ZA200102538B (en) Process for preparing substituted pyridines.
HUP0302821A2 (hu) Eljárás szubsztituált 5-amino-N-fenil-1,2,4-triazol-3-szulfonamid-származékok előállítására
ZA200101529B (en) Process for the preparation of isoindoline.
HK1060732A1 (en) Process for preparing distamycin derivatives.
AU2002228593A8 (en) Process for preparing alpha-(3-arylthio)-acetophenones
GB9914600D0 (en) Novel,process
ZA200207740B (en) Process for preparing alkanesulfonyl pyridines.
HUP0401401A3 (en) Method for preparing 7-quinolinyl-3,5-dihydroxyhept-6-enoate
ZA200207683B (en) Processes for preparing torsemide intermediate.
HU0204443D0 (en) Process for preparing fluoroformates
HU9901547D0 (en) Process for producing n,n-dimethyl-cyclohexyl-amine
MXPA03005571A (es) Procedimiento para preparar bencenosulfonato de 8-arilquinolinio sustituido.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090402